Author’s reply to comments to: Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal


Eur J Ophthalmol 2017; 27(6): e192 - e192




Sara Vaz-Pereira, Inês P. Marques, Rita Flores, on behalf of the Portuguese Multicenter Study Group Of Retinal Vascular Diseases (PORTUGAL)

Article History


Financial support: Dr. Vaz-Pereira reports personal fees and nonfinancial support from Bayer and nonfinancial support from Allergan and Novartis, outside the submitted work. Dr. Flores reports personal fees and nonfinancial support from Allergan and Bayer and nonfinancial support from Novartis, outside the submitted work.
Conflict of interest: None of the authors has conflict of interest with this submission.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.



  •  Department of Ophthalmology, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisbon - Portugal
  •  Department of Ophthalmology, Faculty of Medicine, University of Lisbon, Lisbon - Portugal
  •  AIBILI Associação para Investigação Biomédica e Inovação em Luz e Imagem, Coimbra - Portugal
  •  Department of Ophthalmology, Centro Hospitalar de Lisboa Central, Lisbon - Portugal
  •  Department of Ophthalmology, Nova Medical School, Lisbon - Portugal

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.